These two pathways, ARF/p53 and p16INK4a/RB, are frequently mutated in human tumors, and inactivation of these pathways allows the tumor cell to overcome the senescence barrier and induce tumor transformation [53]. This evidence concerns the gene RB1 and neoplasm.